共 50 条
- [21] Evaluation of a tetravalent dengue vaccine by serostatus and serotype LANCET, 2020, 395 (10234): : 1402 - 1404
- [22] Safety, viremia and immunogenicity of a tetravalent live attenuated ChimeriVax™ dengue vaccine in healthy us adults AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 181 - 182
- [25] Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (07): : 994 - 1000
- [26] Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1562 - 1572
- [27] Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (03): : 426 - 433
- [30] PRECLINICAL EVALUATION OF DENVAX: A CHIMERIC TETRAVALENT DENGUE VACCINE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 263 - 263